Immune Checkpoint Inhibitors Nephrotoxicity

RecruitingOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

April 23, 2028

Study Completion Date

December 30, 2030

Conditions
Kidney InjuryAntineoplastics Toxicity
Interventions
DIAGNOSTIC_TEST

Early kidney damage biomarkers

In the urine samples of these patients, a series of biomarkers of early kidney damage and / or predisposition to kidney damage will be measured.

DIAGNOSTIC_TEST

Predisposition to kidney injury biomarkers

In the urine samples of these patients, a series of biomarkers of predisposition to kidney damage will be measured.

Trial Locations (2)

Unknown

RECRUITING

Servicio de Oncología del CAUSA, Salamanca

RECRUITING

Servicio de oncología del Hospital Universitario de Valladolid, Valladolid

All Listed Sponsors
collaborator

Instituto de Investigación Biomédica de Salamanca

OTHER

collaborator

Hospital Clínico Universitario de Valladolid

OTHER

collaborator

University of Salamanca

OTHER

lead

R. Laura Vicente Vicente

OTHER